Transplant Rejection Prevention

Tacrolimus

Systemic immunosuppressant to prevent organ transplant rejection.

Tacrolimus is a potent systemic calcineurin inhibitor used to prevent rejection in kidney, liver, and heart transplant recipients. It works by suppressing T-lymphocyte activation, thus maintaining graft survival and reducing acute rejection episodes.

Ingredients dosages:

Frequency:

Quantity:

Not sure about dosages? Don't worry, your provider will adjust or confirm your selection after checkout.

Total

$0.00

Here's what happens next:

  1. 1

    Product checkout

    We'll direct you to our product detail page where you can start the checkout process. You'll be charged for the medical consultation but the medication charge is a hold until the official provider review.

  2. 2

    Comprehensive Medical Questionnaire

    After purchase, you'll be directed to a medical assessment covering your medical history, current medications, and specific symptoms.

  3. 3

    Licensed Provider Review

    A licensed healthcare provider reviews your complete medical profile, ensuring this treatment is safe and appropriate for you.

  4. 4

    Personalized Treatment Plan

    Your provider may recommend an adjustment to your prescription based on your full medical profile before approving your treatment.

HIPAA Compliant
Certified Providers
  • Effectively prevents organ rejection in kidney, liver, and heart transplant recipients

  • Provides potent immunosuppression by inhibiting T-lymphocyte activation

  • Demonstrated superior graft survival rates compared to older immunosuppressants

  • Allows dose individualization to optimize balance between efficacy and nephrotoxicity

  • Supports long-term transplant success with consistent therapeutic levels when taken as prescribed

  • Tacrolimus: A calcineurin inhibitor immunosuppressant. It binds to FK-binding proteins, inhibiting calcineurin phosphatase activity, leading to reduced interleukin-2 production and T-cell activation, thus preventing immune-mediated graft rejection

  • Take orally every 12 hours, at the same time each day

  • Administer on an empty stomach (1 hour before or 2 hours after meals) for consistent absorption

  • Swallow capsules whole with water; do not open or chew

  • Regular blood monitoring is required to maintain target tacrolimus trough levels and minimize toxicity

  • Follow transplant team instructions strictly; never adjust doses without medical guidance